The Vanguard Group Discloses Interests in Mural Oncology

The Vanguard Group, Inc. has released a position disclosure form under Rule 8.3 of the Irish Takeover Panel Act concerning its interests in Mural Oncology plc. The document reveals that Vanguard owns and controls 771,459 ordinary shares, representing 4.47% of the company's $0.01 ordinary shares.

The disclosure dated August 28, 2025, indicates no additional interests in other potential offerors or offerees related to Mural Oncology. There was a minor sale activity, with 80 shares sold at a price of $2.07 per share.

Further sections of the form outline that no cash-settled derivatives or stock-settled derivatives are listed. No additional indemnity or option arrangements exist between Vanguard and any parties involved. Finally, the form confirms that no Supplemental Form 8 is attached.